Genelux Corporation
genelux.comWhat Do They Do?
Develops virus-based cancer treatment candidates for patients with difficult-to-treat tumors, led by Olvi-Vec.
10-K for FY2025, filed Mar 19, 2026
Who Do They Compete With?
Competes with Abbvie, Eisai, Roche/Genentech, Merck, GSK, AstraZeneca, Tolmar, Verstem Oncology, Corcept Therapeutics, Novartis, Pfizer, Johnson & Johnson, Eli Lilly, Bristol Myers Squibb, and Amgen
10-K for FY2025, filed Mar 19, 2026Currently marketed products for ovarian cancer include brand and generic chemotherapies, along with the following brand products (some of…View ↗
Loading...
